DBV Technologies | DBVT - Trade Debtors


DBV Technologies reported $15.97M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amarin USD 127.31M 8.18M Sep/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
DBV Technologies USD 15.97M 279K Sep/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
United Therapeutics USD 350.2M 52.5M Dec/2025